BCTX

Briacell Therapeutics Corp

NASDAQ: BCTX · HEALTHCARE · BIOTECHNOLOGY

$4.08

-5.52% today

Updated 2026-06-05

Market cap

$23.84M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.84

Dividend yield

—

52W range

$3 – $32

Volume

0.2M

Market cap

$23.84M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.84

Dividend yield

—

52W range

$3 – $32

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →199 stocks currently score above 75

Price targets

Analyst target

$150.00

+3576.47%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-7.08M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	—	$0.00
Net income	$-34.42M	$-27.11M	$-4.79M	$-36.49M	$-7.16M
EPS	—	—	—	—	$-0.84
Free cash flow	$-15.87M	$-31.89M	$-33.59M	$-39.07M	$-7.08M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BCTX	$23.84M	23	4.3	3.0	5.0	6.0	—	Avoid
LLY	$1.01T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$567.28B	57	4.7	9.0	3.3	6.0	-67.79%	Buy
ABBV	$391.50B	63	4.0	8.0	4.0	5.0	-48.06%	Buy
UNH	$373.28B	54	5.3	5.5	4.0	5.5	-26.94%	Buy
NVS	$289.19B	49	3.3	9.0	3.3	4.5	-65.15%	Hold

Smart narrative

Briacell Therapeutics Corp trades at $4.08. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Briacell Therapeutics Corp's stock price?

Briacell Therapeutics Corp (BCTX) trades at $4.08.

Is Briacell Therapeutics Corp overvalued?

Briacell Therapeutics Corp carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Briacell Therapeutics Corp (BCTX)?

The 12-month analyst consensus target is $150.00, about 3576.5% above the current $4.08. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-124.86%

Beta1.64

50D MA$3.80

200D MA$6.80

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BCTX vs LLY →BCTX vs JNJ →BCTX vs ABBV →Stock screener →